No. 2 / 2025Zealand Pharma Announces Financial Results for the Full Year 2024A transformational year with significant ...

CEO Adam Steensberg emphasized 2024 as a transformational year for Zealand Pharma, highlighting significant clinical advancements in its obesity pipeline, particularly with petrelintide and ...

Specialised Therapeutics welcomes the registration of YORVIPATH by the Therapeutic Goods Administration, “for the treatment of chronic ...

The environmental testing market is estimated at USD 7.43 billion in 2025 and is projected to reach USD 9.32 billion by 2030, at a CAGR of 4.6% ...

U.S.-based hedge fund Viking Global built a $526 million-worth new position in planemaker Boeing in the fourth quarter, with 2.9 million shares, and roughly doubled bets on JPMorgan Chase, a ...

Rewriting History, Trump Blames Ukraine for War and Calls Zelensky ‘Dictator’ President Trump made an array of false claims as he tried to cast President Volodymyr Zelensky as a villain who ...

Au revoir, American Riviera Orchard. Meghan, the Duchess of Sussex, has rebranded her fledgling company to As Ever just weeks ...

Zydus Lifesciences Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, ...